2 completed, 1 not yet recruiting, 1 unknown. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Not yet recruiting 1, Unknown 1 |
Follow Ozempic®: new trials by email Literature Review of Ozempic® trials Research Report on Ozempic®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes F027, Ozempic® - Type 2 Diabetes (T2DM) | Phase 3 | Not yet recruiting | Shandong New Time Pharmaceutical Co., LTD | 496 | 2025-08-01 | 2025-07-01 |
| Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes Semaglutide Injection, Semaglutide Injection(Ozempic®), Metformin - Type 2 Diabetes Mellitus | Phase 3 | Unknown | Chengdu Brilliant Pharmaceutical Co., Ltd. | 478 | 2024-04-01 | 2024-04-01 |
| Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellitus semaglutide injection (HD1916), Ozempic® - Type 2 Diabetes Mellitus | Phase 3 | Completed | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 506 | 2024-02-23 | 2025-07-11 |
| Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes Ozempic®, HDG1901 - Type 2 Diabetes | Phase 3 | Completed | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 494 | 2023-09-20 | 2025-07-28 |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · Chengdu Brilliant Pharmaceutical Co., Ltd. (1) · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (1) · Shandong New Time Pharmaceutical Co., LTD (1)
China (2)
Dalong Zhu, PhD (1)